×
About 2,580 results

ALLMedicine™ Gallbladder Cancer Center

Research & Reviews  903 results

Competing risk analysis of cardiovascular death in patients with primary gallbladder ca...
https://doi.org/10.1002/cam4.5104
Cancer Medicine; Chen C, Xu F et. al.

Aug 4th, 2022 - Developments in medical technology are resulting in continuous decreases in the cancer mortality rate of patients with gallbladder cancer, while non-cancer deaths in cancer patients are becoming more common. The main cause of this is cardiovascula...

HHLA2 promotes tumor progression by long non‑coding RNA H19 in human gallbladder cancer.
https://doi.org/10.3892/ijo.2022.5402
International Journal of Oncology; Zhang Y, Li H et. al.

Aug 4th, 2022 - Advanced gallbladder cancer (GBC) is one of the most malignant of all types of biliary tract cancers that is associated with poor prognosis and high mortality. Accumulating evidence suggest that the B7 family of proteins serve an essential role in...

Heterogeneity of management practices surrounding operable gallbladder cancer - results...
https://doi.org/10.1016/j.hpb.2022.06.014
HPB : the Official Journal of the International Hepato Pa... Balakrishnan A, Jah A et. al.

Aug 4th, 2022 - Gallbladder cancer (GBC) is an aggressive, uncommon malignancy, with variation in operative approaches adopted across centres and few large-scale studies to guide practice. We aimed to identify the extent of heterogeneity in GBC internationally to...

Laparoscopic segment 4b+5 liver resection for stage T3 gallbladder cancer.
https://doi.org/10.1007/s00464-022-09325-4
Surgical Endoscopy; Huang L, Zhang C et. al.

Jul 30th, 2022 - There is still controversy over whether to perform laparoscopic surgery for T3 stage gallbladder cancer. In addition, the necessity of segment 4b+5 liver resection for stage T3 gallbladder has not been reported. This article aims to explore the sa...

Multimodality Imaging of Cholecystectomy Complications.
https://doi.org/10.1148/rg.210106
Radiographics : a Review Publication of the Radiological ... Patel N, Jensen KK et. al.

Jul 30th, 2022 - Cholecystectomy is one of the most common surgeries performed in the United States. Although complications are uncommon, the high incidence of this surgery means that a radiologist will likely encounter these complications in practice. Complicatio...

see more →

Guidelines  6 results

Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
https://doi.org/10.6004/jnccn.2021.0022
Journal of the National Comprehensive Cancer Network : JN... Benson AB, D'Angelica MI et. al.

May 25th, 2021 - The NCCN Guidelines for Hepatobiliary Cancers focus on the screening, diagnosis, staging, treatment, and management of hepatocellular carcinoma (HCC), gallbladder cancer, and cancer of the bile ducts (intrahepatic and extrahepatic cholangiocarcino...

Clinical practice guidelines for the management of biliary tract cancers 2019: The 3rd ...
https://doi.org/10.1002/jhbp.870
Journal of Hepato-biliary-pancreatic Sciences; Nagino M, Hirano S et. al.

Dec 2nd, 2020 - The Japanese Society of Hepato-Biliary-Pancreatic Surgery launched the clinical practice guidelines for the management of biliary tract cancers (cholangiocarcinoma, gallbladder cancer, and ampullary cancer) in 2007, then published the 2nd version ...

AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With...
https://doi.org/10.1016/j.cgh.2019.07.011
Clinical Gastroenterology and Hepatology : the Official C... Bowlus CL, Lim JK et. al.

Jul 16th, 2019 - The purpose of this clinical practice update is to define key principles in the surveillance of hepatobiliary cancers including cholangiocarcinoma, gallbladder adenocarcinoma, and hepatocellular carcinoma in patients with primary sclerosing cholan...

Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline.
https://doi.org/10.1200/JCO.18.02178
Journal of Clinical Oncology : Official Journal of the Am... Shroff RT, Kennedy EB et. al.

Mar 12th, 2019 - To develop an evidence-based clinical practice guideline to assist in clinical decision making for patients with resected biliary tract cancer. ASCO convened an Expert Panel to conduct a systematic review of the literature on adjuvant therapy for ...

Gallbladder cancer: expert consensus statement.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527853
HPB : the Official Journal of the International Hepato Pa... Aloia TA, Járufe N et. al.

Jul 15th, 2015 - An American Hepato-Pancreato-Biliary Association (AHPBA)-sponsored consensus meeting of expert panellists was convened on 15 January 2014 to review current evidence on the management of gallbladder carcinoma in order to establish practice guidelin...

see more →

Clinicaltrials.gov  69 results

Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tum...
https://clinicaltrials.gov/ct2/show/NCT04683939

Jul 27th, 2022 - This trial is an open-label, multi-site, Phase I/IIa dose escalation, safety, and pharmacokinetic (PK) trial of BNT141 followed by expansion cohorts in patients with CLDN18.2-positive tumors. The trial design consists of three parts: Part 1A is a ...

Study of TT-00420 Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors
https://clinicaltrials.gov/ct2/show/NCT04742959

Jul 21st, 2022 - Study consists of three arms, Arm A is a Phase Ib/II study of TT-00420 tablet monotherapy, Arm B is a Phase Ib/II study of TT-00420 tablet in combination with nab-paclitaxel (Abraxane®) and Arm C is a PK run-in study of TT-00420 tablet. Arm A: TT-...

Comparing the Current Hydration Regimen for the ABC02 Chemotherapy Regimen Versus a Shorter Hydration
https://clinicaltrials.gov/ct2/show/NCT04362449

Jul 15th, 2022 - The ABC02 treatment regime was established in 2010 following publication in the New England Journal of Medicine and has since become the standard of care treatment of bile duct cancers otherwise known as cholangiocarcinomas, as well as gallbladder...

A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients (MATINS)
https://clinicaltrials.gov/ct2/show/NCT03733990

Jul 14th, 2022 - This is a first in human study to identify whether FP-1305 is suitable to use in humans. The previous pre-clinical studies have demonstrated that FP-1305 binds to a receptor known as CLEVER-1. CLEVER-1 has been shown to support tumour growth. No s...

Ramucirumab in Treating Patients With Advanced or Metastatic, Previously Treated Biliary Cancers That Cannot Be Removed by Surgery
https://clinicaltrials.gov/ct2/show/NCT02520141

Jul 11th, 2022 - PRIMARY OBJECTIVES: I. Determine the progression-free survival (PFS) of ramucirumab in advanced biliary cancers (intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and gallbladder cancer) who have received prior chemotherapy. SECOND...

see more →

News  47 results

New insights into worldwide biliary tract cancer incidence, mortality
https://www.mdedge.com/internalmedicine/article/256218/gastroenterology/new-insights-worldwide-biliary-tract-cancer
Jim Kling

Jul 12th, 2022 - Incidence and mortality for biliary tract cancer (BTC) are both on the rise worldwide, according to a new analysis of data from the International Agency for Research on Cancer and the World Health Organization. This diverse group of hepatic and pe.

Durvalumab Plus Chemotherapy Improves Survival in Advanced Biliary Tract Cancer
https://www.onclive.com/view/durvalumab-plus-chemotherapy-improves-survival-in-advanced-biliary-tract-cancer

Jan 18th, 2022 - Treatment with the PD-L1 inhibitor durvalumab (Imfinzi) in combination with gemcitabine and cisplatin resulted in significantly improved overall survival (OS) vs placebo plus chemotherapy in patients with advanced biliary tract cancer (BTC), accor...

Fast Five Quiz: Gallbladder Disease
https://reference.medscape.com/viewarticle/964010

Dec 8th, 2021 - Gallbladder disease is a broad term that can refer to infection, inflammation, or biliary blockage due to gallstones. From cholecystitis to gallbladder cancer, these conditions are both common and costly. Can you recognize common gallbladder disea...

Advanced Glycation Endproducts and Liver Cancer: Findings Unexpected, Show Inverse Relationship
https://www.medscape.com/viewarticle/951914

May 26th, 2021 - Contrary to expectations, high dietary intake of advanced glycation endproducts (AGEs), including those from foods that are deep fried, grilled, or broiled, was associated with a lower risk of hepatocellular carcinoma (HCC) in a large, multination...

Second Resections in Gallbladder Cancer Tied to Better OS, but Barely Used
https://www.medpagetoday.com/hematologyoncology/othercancers/92769

May 24th, 2021 - Second definitive surgery in gallbladder cancer was associated with improved overall survival (OS), a retrospective study found, but the practice goes largely underutilized. In a study of 6,175 patients, those who underwent re-resection -- defined...

see more →

Patient Education  7 results see all →